Recombinant multi-species CXCL9/MIG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CXCL9/MIG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This antimicrobial gene is part of a chemokine superfamily that encodes secreted proteins involved in immunoregulatory and inflammatory processes. The protein encoded is thought to be involved in T cell trafficking. The encoded protein binds to C-X-C motif chemokine 3 and is a chemoattractant for lymphocytes but not for neutrophils. [provided by RefSeq, Aug 2020]
The Alternative Names of target: C-X-C motif chemokine 9,CMK,CXCL9,Cxcl9,Gamma-interferon-induced monokine,Humig,MIG,MIG),Mig,Monokine induced by interferon-gamma (HuMIG,MuMIG,SCYB9,Scyb9,Small-inducible cytokine B9,crg-10

Target products collectionGo to CXCL9/MIG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T56349-Ag-1/ GM-Tg-hg-T56349-Ag-2 Human CXCL9/MIG protein Human
GM-Tg-rg-T56349-Ag-1/ GM-Tg-rg-T56349-Ag-2 Rat CXCL9/MIG protein Rat
GM-Tg-mg-T56349-Ag-1/ GM-Tg-mg-T56349-Ag-2 Mouse CXCL9/MIG protein Mouse
GM-Tg-cynog-T56349-Ag-1/ GM-Tg-cynog-T56349-Ag-2 Cynomolgus/Rhesus macaque CXCL9/MIG protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T56349-Ag-1/ GM-Tg-felg-T56349-Ag-2 Feline CXCL9/MIG protein Feline
GM-Tg-cang-T56349-Ag-1/ GM-Tg-cang-T56349-Ag-2 Canine CXCL9/MIG protein Canine
GM-Tg-bovg-T56349-Ag-1/ GM-Tg-bovg-T56349-Ag-2 Bovine CXCL9/MIG protein Bovine
GM-Tg-equg-T56349-Ag-1/ GM-Tg-equg-T56349-Ag-2 Equine CXCL9/MIG protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T56349-Ag-1/ GM-Tg-hg-T56349-Ag-2; GM-Tg-rg-T56349-Ag-1/ GM-Tg-rg-T56349-Ag-2;
GM-Tg-mg-T56349-Ag-1/ GM-Tg-mg-T56349-Ag-2; GM-Tg-cynog-T56349-Ag-1/ GM-Tg-cynog-T56349-Ag-2;
GM-Tg-felg-T56349-Ag-1/ GM-Tg-felg-T56349-Ag-2; GM-Tg-cang-T56349-Ag-1/ GM-Tg-cang-T56349-Ag-2;
GM-Tg-bovg-T56349-Ag-1/ GM-Tg-bovg-T56349-Ag-2; GM-Tg-equg-T56349-Ag-1/ GM-Tg-equg-T56349-Ag-2
Products Name CXCL9/MIG protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CXCL9/MIG
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CXCL9/MIG protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.